# Peloton Interactive, Inc.: financial statements, quarterly

PTON · Nasdaq · CIK 1639825 · [Consumer discretionary](/sectors/consumer-discretionary.md) · fiscal year ends Jun 30

Pages: [Overview](/companies/pton.md) · [Financials](/companies/pton/financials.md) · [Filings](/companies/pton/filings.md) · [Insiders](/companies/pton/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/pton/financials.md?period=annual).

## Income statement

| Line item | Unit | Q1 FY2024 (2023-09-30) | Q2 FY2024 (2023-12-31) | Q3 FY2024 (2024-03-31) | Q4 FY2024 (2024-06-30) | Q1 FY2025 (2024-09-30) | Q2 FY2025 (2024-12-31) | Q3 FY2025 (2025-03-31) | Q4 FY2025 (2025-06-30) | Q1 FY2026 (2025-09-30) | Q2 FY2026 (2025-12-31) | Q3 FY2026 (2026-03-31) | Q4 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [596](/filings/0001639825-24-000163.md) | [744](/filings/0001639825-25-000026.md) | [718](/filings/0001639825-25-000081.md) | [644 d](/filings/0001639825-26-000038.md) | [586](/filings/0001639825-25-000185.md) | [674](/filings/0001639825-26-000008.md) | [624](/filings/0001639825-26-000022.md) | [607 d](/filings/0001639825-26-000038.md) | [551](/filings/0001639825-25-000185.md) | [657](/filings/0001639825-26-000008.md) | [631](/filings/0001639825-26-000022.md) | [608 d](/filings/0001639825-26-000038.md) |
| Cost of revenue | $m | [310](/filings/0001639825-24-000163.md) | [444](/filings/0001639825-25-000026.md) | [408](/filings/0001639825-25-000081.md) | [332 d](/filings/0001639825-26-000038.md) | [282](/filings/0001639825-25-000185.md) | [356](/filings/0001639825-26-000008.md) | [306](/filings/0001639825-26-000022.md) | [279 d](/filings/0001639825-26-000038.md) | [267](/filings/0001639825-25-000185.md) | [325](/filings/0001639825-26-000008.md) | [304](/filings/0001639825-26-000022.md) | [263 d](/filings/0001639825-26-000038.md) |
| Gross profit | $m | [285](/filings/0001639825-24-000163.md) | [299](/filings/0001639825-25-000026.md) | [310](/filings/0001639825-25-000081.md) | [312 d](/filings/0001639825-26-000038.md) | [304](/filings/0001639825-25-000185.md) | [318](/filings/0001639825-26-000008.md) | [318](/filings/0001639825-26-000022.md) | [328 d](/filings/0001639825-26-000038.md) | [284](/filings/0001639825-25-000185.md) | [331](/filings/0001639825-26-000008.md) | [327](/filings/0001639825-26-000022.md) | [344 d](/filings/0001639825-26-000038.md) |
| Research and development | $m | [78.7](/filings/0001639825-24-000163.md) | [79.9](/filings/0001639825-25-000026.md) | [76.8](/filings/0001639825-25-000081.md) | [69.4 d](/filings/0001639825-26-000038.md) | [58.5](/filings/0001639825-25-000185.md) | [60.3](/filings/0001639825-26-000008.md) | [59.6](/filings/0001639825-26-000022.md) | [55.8 d](/filings/0001639825-26-000038.md) | [62.1](/filings/0001639825-25-000185.md) | [65.0](/filings/0001639825-26-000008.md) | [58.8](/filings/0001639825-26-000022.md) | [56.9 d](/filings/0001639825-26-000038.md) |
| Operating income | $m | [(132)](/filings/0001639825-24-000163.md) | [(187)](/filings/0001639825-25-000026.md) | [(146)](/filings/0001639825-25-000081.md) | [(63.3) d](/filings/0001639825-26-000038.md) | [12.5](/filings/0001639825-25-000185.md) | [(45.9)](/filings/0001639825-26-000008.md) | [(32.4)](/filings/0001639825-26-000022.md) | [29.6 d](/filings/0001639825-26-000038.md) | [41.3](/filings/0001639825-25-000185.md) | [(14.3)](/filings/0001639825-26-000008.md) | [52.5](/filings/0001639825-26-000022.md) | [81.2 d](/filings/0001639825-26-000038.md) |
| Interest expense | $m | [27.2](/filings/0001639825-23-000164.md) | [27.7](/filings/0001639825-24-000010.md) | [27.7](/filings/0001639825-24-000055.md) | [29.9 d](/filings/0001639825-26-000038.md) | [35.4](/filings/0001639825-25-000185.md) | [34.6](/filings/0001639825-26-000008.md) | [32.6](/filings/0001639825-26-000022.md) | [31.9 d](/filings/0001639825-26-000038.md) | [32.3](/filings/0001639825-25-000185.md) | [31.5](/filings/0001639825-26-000008.md) | [30.0](/filings/0001639825-26-000022.md) | [30.0 d](/filings/0001639825-26-000038.md) |
| Income tax | $m | [0.8](/filings/0001639825-24-000163.md) | [(1.7)](/filings/0001639825-25-000026.md) | [0.6](/filings/0001639825-25-000081.md) | [0.1 d](/filings/0001639825-26-000038.md) | [0.8](/filings/0001639825-25-000185.md) | [0.7](/filings/0001639825-26-000008.md) | [0.8](/filings/0001639825-26-000022.md) | [1.1 d](/filings/0001639825-26-000038.md) | [0.7](/filings/0001639825-25-000185.md) | [(0.2)](/filings/0001639825-26-000008.md) | [0.4](/filings/0001639825-26-000022.md) | [(1.0) d](/filings/0001639825-26-000038.md) |
| Net income | $m | [(159)](/filings/0001639825-24-000163.md) | [(195)](/filings/0001639825-25-000026.md) | [(167)](/filings/0001639825-25-000081.md) | [(30.5) d](/filings/0001639825-26-000038.md) | [(0.9)](/filings/0001639825-25-000185.md) | [(92.0)](/filings/0001639825-26-000008.md) | [(47.7)](/filings/0001639825-26-000022.md) | [21.6 d](/filings/0001639825-26-000038.md) | [13.9](/filings/0001639825-25-000185.md) | [(38.8)](/filings/0001639825-26-000008.md) | [26.4](/filings/0001639825-26-000022.md) | [61.6 d](/filings/0001639825-26-000038.md) |
| Diluted EPS | $ per share | [(0.44)](/filings/0001639825-24-000163.md) | [(0.54)](/filings/0001639825-25-000026.md) | [(0.45)](/filings/0001639825-25-000081.md) | not reported | [0.00](/filings/0001639825-25-000185.md) | [(0.24)](/filings/0001639825-26-000008.md) | [(0.12)](/filings/0001639825-26-000022.md) | not reported | [0.03](/filings/0001639825-25-000185.md) | [(0.09)](/filings/0001639825-26-000008.md) | [0.06](/filings/0001639825-26-000022.md) | not reported |
| Basic EPS | $ per share | [(0.44)](/filings/0001639825-24-000163.md) | [(0.54)](/filings/0001639825-25-000026.md) | [(0.45)](/filings/0001639825-25-000081.md) | not reported | [0.00](/filings/0001639825-25-000185.md) | [(0.24)](/filings/0001639825-26-000008.md) | [(0.12)](/filings/0001639825-26-000022.md) | not reported | [0.03](/filings/0001639825-25-000185.md) | [(0.09)](/filings/0001639825-26-000008.md) | [0.06](/filings/0001639825-26-000022.md) | not reported |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfRevenue
- Gross profit: us-gaap:GrossProfit
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q1 FY2024 (2023-09-30) | Q2 FY2024 (2023-12-31) | Q3 FY2024 (2024-03-31) | FY2024 (2024-06-30) | Q1 FY2025 (2024-09-30) | Q2 FY2025 (2024-12-31) | Q3 FY2025 (2025-03-31) | FY2025 (2025-06-30) | Q1 FY2026 (2025-09-30) | Q2 FY2026 (2025-12-31) | Q3 FY2026 (2026-03-31) | FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [749](/filings/0001639825-23-000164.md) | [738](/filings/0001639825-24-000010.md) | [795](/filings/0001639825-24-000055.md) | [698](/filings/0001639825-25-000138.md) | [722](/filings/0001639825-24-000163.md) | [829](/filings/0001639825-25-000026.md) | [914](/filings/0001639825-25-000081.md) | [1,040](/filings/0001639825-26-000038.md) | [1,104](/filings/0001639825-25-000185.md) | [1,180](/filings/0001639825-26-000008.md) | [1,126](/filings/0001639825-26-000022.md) | [1,207](/filings/0001639825-26-000038.md) |
| Current assets | $m | [1,588](/filings/0001639825-23-000164.md) | [1,527](/filings/0001639825-24-000010.md) | [1,421](/filings/0001639825-24-000055.md) | [1,266](/filings/0001639825-25-000138.md) | [1,285](/filings/0001639825-24-000163.md) | [1,308](/filings/0001639825-25-000026.md) | [1,340](/filings/0001639825-25-000081.md) | [1,438](/filings/0001639825-26-000038.md) | [1,512](/filings/0001639825-25-000185.md) | [1,556](/filings/0001639825-26-000008.md) | [1,439](/filings/0001639825-26-000022.md) | [1,489](/filings/0001639825-26-000038.md) |
| Total assets | $m | [2,673](/filings/0001639825-23-000164.md) | [2,569](/filings/0001639825-24-000010.md) | [2,409](/filings/0001639825-24-000055.md) | [2,185](/filings/0001639825-25-000138.md) | [2,157](/filings/0001639825-24-000163.md) | [2,110](/filings/0001639825-25-000026.md) | [2,065](/filings/0001639825-25-000081.md) | [2,125](/filings/0001639825-26-000038.md) | [2,170](/filings/0001639825-25-000185.md) | [2,165](/filings/0001639825-26-000008.md) | [2,017](/filings/0001639825-26-000022.md) | [2,056](/filings/0001639825-26-000038.md) |
| Current liabilities | $m | [750](/filings/0001639825-23-000164.md) | [793](/filings/0001639825-24-000010.md) | [746](/filings/0001639825-24-000055.md) | [685](/filings/0001639825-25-000138.md) | [640](/filings/0001639825-24-000163.md) | [635](/filings/0001639825-25-000026.md) | [812](/filings/0001639825-25-000081.md) | [804](/filings/0001639825-26-000038.md) | [795](/filings/0001639825-25-000185.md) | [785](/filings/0001639825-26-000008.md) | [578](/filings/0001639825-26-000022.md) | [525](/filings/0001639825-26-000038.md) |
| Total liabilities | $m | [3,044](/filings/0001639825-23-000164.md) | [3,069](/filings/0001639825-24-000010.md) | [2,999](/filings/0001639825-24-000055.md) | [2,704](/filings/0001639825-25-000138.md) | [2,637](/filings/0001639825-24-000163.md) | [2,607](/filings/0001639825-25-000026.md) | [2,556](/filings/0001639825-25-000081.md) | [2,539](/filings/0001639825-26-000038.md) | [2,517](/filings/0001639825-25-000185.md) | [2,491](/filings/0001639825-26-000008.md) | [2,259](/filings/0001639825-26-000022.md) | [2,196](/filings/0001639825-26-000038.md) |
| Long-term debt | $m | not reported | not reported | not reported | [1,549](/filings/0001639825-24-000128.md) | [1,547](/filings/0001639825-24-000163.md) | [1,544](/filings/0001639825-25-000026.md) | [1,542](/filings/0001639825-25-000081.md) | [1,539](/filings/0001639825-25-000138.md) | [1,537](/filings/0001639825-25-000185.md) | [1,534](/filings/0001639825-26-000008.md) | [1,333](/filings/0001639825-26-000022.md) | [1,330](/filings/0001639825-26-000038.md) |
| Current portion of debt | $m | [7.5](/filings/0001639825-23-000164.md) | [7.5](/filings/0001639825-24-000010.md) | [7.5](/filings/0001639825-24-000055.md) | [10.0](/filings/0001639825-25-000138.md) | [10.0](/filings/0001639825-24-000163.md) | [10.0](/filings/0001639825-25-000026.md) | [208](/filings/0001639825-25-000081.md) | [209](/filings/0001639825-26-000038.md) | [209](/filings/0001639825-25-000185.md) | [209](/filings/0001639825-26-000008.md) | [10.0](/filings/0001639825-26-000022.md) | [10.0](/filings/0001639825-26-000038.md) |
| Shareholders' equity | $m | [(371)](/filings/0001639825-25-000026.md) | [(499)](/filings/0001639825-25-000081.md) | [(590)](/filings/0001639825-25-000081.md) | [(519)](/filings/0001639825-26-000038.md) | [(480)](/filings/0001639825-26-000008.md) | [(497)](/filings/0001639825-26-000022.md) | [(491)](/filings/0001639825-26-000022.md) | [(414)](/filings/0001639825-26-000038.md) | [(347)](/filings/0001639825-26-000008.md) | [(327)](/filings/0001639825-26-000022.md) | [(242)](/filings/0001639825-26-000022.md) | [(140)](/filings/0001639825-26-000038.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q1 FY2024 (2023-09-30) | Q2 FY2024 (2023-12-31) | Q3 FY2024 (2024-03-31) | Q4 FY2024 (2024-06-30) | Q1 FY2025 (2024-09-30) | Q2 FY2025 (2024-12-31) | Q3 FY2025 (2025-03-31) | Q4 FY2025 (2025-06-30) | Q1 FY2026 (2025-09-30) | Q2 FY2026 (2025-12-31) | Q3 FY2026 (2026-03-31) | Q4 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(79.2)](/filings/0001639825-24-000163.md) | [(31.2) d](/filings/0001639825-25-000026.md) | [11.6 d](/filings/0001639825-25-000081.md) | [32.7 d](/filings/0001639825-26-000038.md) | [12.5](/filings/0001639825-25-000185.md) | [107 d](/filings/0001639825-26-000008.md) | [96.7 d](/filings/0001639825-26-000022.md) | [117 d](/filings/0001639825-26-000038.md) | [71.9](/filings/0001639825-25-000185.md) | [71.9 d](/filings/0001639825-26-000008.md) | [153 d](/filings/0001639825-26-000022.md) | [91.1 d](/filings/0001639825-26-000038.md) |
| Capital expenditure | $m | [4.1](/filings/0001639825-24-000163.md) | [5.9 d](/filings/0001639825-25-000026.md) | [3.0 d](/filings/0001639825-25-000081.md) | [6.7 d](/filings/0001639825-26-000038.md) | [1.8](/filings/0001639825-25-000185.md) | [0.7 d](/filings/0001639825-26-000008.md) | [2.1 d](/filings/0001639825-26-000022.md) | [4.7 d](/filings/0001639825-26-000038.md) | [4.5](/filings/0001639825-25-000185.md) | [0.9 d](/filings/0001639825-26-000008.md) | [2.2 d](/filings/0001639825-26-000022.md) | [2.3 d](/filings/0001639825-26-000038.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets

## Shares

| Line item | Unit | Q1 FY2023 (2022-09-30) | Q2 FY2023 (2022-12-31) | Q3 FY2023 (2023-03-31) | Q1 FY2024 (2023-09-30) | Q2 FY2024 (2023-12-31) | Q3 FY2024 (2024-03-31) | Q1 FY2025 (2024-09-30) | Q2 FY2025 (2024-12-31) | Q3 FY2025 (2025-03-31) | Q1 FY2026 (2025-09-30) | Q2 FY2026 (2025-12-31) | Q3 FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [339](/filings/0001639825-23-000164.md) | [342](/filings/0001639825-24-000010.md) | [350](/filings/0001639825-24-000055.md) | [359](/filings/0001639825-24-000163.md) | [362](/filings/0001639825-25-000026.md) | [368](/filings/0001639825-25-000081.md) | [379](/filings/0001639825-25-000185.md) | [386](/filings/0001639825-26-000008.md) | [394](/filings/0001639825-26-000022.md) | [430](/filings/0001639825-25-000185.md) | [421](/filings/0001639825-26-000008.md) | [512](/filings/0001639825-26-000022.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:45 ET. No prices; not investment advice.